82 studies found for:    immune thrombocytopenia OR immune thrombocytopenic purpura OR idiopathic thrombocytopenic purpura | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
1 Recruiting Rifaximin for Chronic Immune Activation in People With HIV
Condition: HIV
Intervention: Drug: Rifaximin/ Placebo
2 Recruiting Health-related Quality of Life in Rare Kidney Stone
Conditions: Primary Hyperoxaluria;   Cystinuria;   Adenine Phosphoribosyl Transferase Deficiency;   Dent Disease
3 Recruiting Protein, Amino Acids & Insulin & Glucagon Secretion in Humans
Conditions: Type 2 Diabetes;   Metabolic Syndrome
Intervention: Other: water, glucose with or without amino acid
4 Recruiting Chronic Pain Risk Associated With Menstrual Period Pain
Conditions: Cystitis, Interstitial;   Dysmenorrhea;   Migraine Disorders;   Pelvic Pain;   Endometriosis;   Visceral Pain
Intervention: Drug: microgestin 1/20
5 Recruiting Molecular Basis of Human Phagocyte Interactions With Bacterial Pathogens
Condition: Normal Neutrophil Function
6 Recruiting Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy
Condition: HIV Infection
Intervention: Drug: Pegylated Interferon Alpha 2b (PEGINTRON)
7 Recruiting Development of Countermeasures Against Adverse Metabolic Effects of Shift Work
Condition: Circadian Dysregulation
Intervention: Behavioral: Meal schedule
8 Recruiting Effect of Dietary Habits on Metabolic Health
Conditions: Overweight;   Obesity;   Prediabetes;   Meals
Intervention: Behavioral: Meal schedule
9 Recruiting Evaluation of MiSeq for Microbial Identification in Specimens
Condition: Bloodstream Infections
10 Unknown  Prevalence of Carbohydrate Intolerance in Lean and Obese Children
Conditions: Obesity;   Glucose Intolerance;   Diabetes;   Acanthosis Nigricans
11 Recruiting Effect of Increasing Doses of Cystine Binding Thiol Drugs on Cystine Capacity in Patients With Cystinuria
Condition: Cystinuria
Intervention: Drug: CBTD 0-3 gm
12 Unknown  Medication Intervention in Transitional Care to Optimize Outcomes & Costs for CKD & ESRD
Conditions: Chronic Kidney Disease;   End-Stage Renal Disease
Interventions: Other: Medication Information Transfer Intervention;   Other: Usual care for hospital discharge
13 Recruiting Intensity-Modulated Proton Beam Therapy (IMPT) Versus Intensity-Modulated Photon Therapy (IMRT)
Condition: Head And Neck Cancer
Interventions: Radiation: Intensity-Modulated X-Ray Therapy (IMRT);   Radiation: Intensity-Modulated Proton Beam Therapy (IMPT);   Procedure: Modified barium swallow (MBS);   Behavioral: Questionnaires
14 Recruiting Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Conditions: Recurrent Melanoma;   Stage IIIC Skin Melanoma;   Stage IV Skin Melanoma
Interventions: Biological: Bevacizumab;   Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis
15 Recruiting Pembrolizumab and Ziv-aflibercept in Treating Patients With Advanced Solid Tumors
Conditions: Adult Solid Neoplasm;   Metastatic Melanoma;   Metastatic Renal Cell Cancer;   Recurrent Colorectal Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Renal Cell Carcinoma;   Stage IV Ovarian Cancer;   Stage IVA Colorectal Cancer;   Stage IVB Colorectal Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab;   Biological: Ziv-Aflibercept
16 Recruiting Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy
Condition: Malignant Mesothelioma
Interventions: Drug: pemetrexed disodium;   Other: clinical observation
17 Recruiting Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Conditions: Recurrent Melanoma of the Skin;   Stage IIIA Skin Melanoma;   Stage IIIB Skin Melanoma;   Stage IIIC Skin Melanoma;   Stage IV Skin Melanoma
Interventions: Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab;   Other: Quality-of-Life Assessment;   Biological: Sargramostim
18 Recruiting Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: clofarabine;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: decitabine
19 Unknown  Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia;   Lymphoma
Intervention: Other: biologic sample preservation procedure
20 Not yet recruiting Diuretic Comparison Project
Condition: Hypertension
Interventions: Drug: Hydrochlorothiazide;   Drug: Chlorthalidone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years